These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Merck to pay $5bn in rofecoxib claims. Charatan F BMJ; 2007 Nov; 335(7628):1011. PubMed ID: 18006982 [No Abstract] [Full Text] [Related]
6. AMCP Seeks an End to 20 Years Of Confusion Over FDAMA Section 114. Dalzell MD Manag Care; 2016 Sep; 25(9):43-45. PubMed ID: 28121576 [TBL] [Abstract][Full Text] [Related]
8. AstraZeneca pays $520m fine for off label marketing. Tanne JH BMJ; 2010 Apr; 340():c2380. PubMed ID: 20430836 [No Abstract] [Full Text] [Related]
9. Bristol-Myers Squibb swallows last of antibody pioneers. Allison M Nat Biotechnol; 2009 Sep; 27(9):781-3. PubMed ID: 19741612 [No Abstract] [Full Text] [Related]
10. The House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry'. Too much too late? Kerwin R J Psychopharmacol; 2007 Mar; 21(2):131-3. PubMed ID: 17329287 [No Abstract] [Full Text] [Related]
11. Deal watch: Bristol-Myers Squibb acquires potential keys to treating rheumatoid arthritis. Cully M Nat Rev Drug Discov; 2016 May; 15(5):301. PubMed ID: 27139990 [No Abstract] [Full Text] [Related]
12. Bristol-Myers Squibb launches $2 million AIDS grant program. AIDS Read; 2000 Apr; 10(4):208. PubMed ID: 10808603 [No Abstract] [Full Text] [Related]
13. Indian generics manufacturer Ranbaxy agrees to pay $500m to settle US fraud and drug safety charges. Kay M BMJ; 2013 May; 346():f3536. PubMed ID: 23723460 [No Abstract] [Full Text] [Related]
14. Legal aspects of on-line pharmacy: free movement of goods is not tantamount to free provision of services! Michel L Acta Chir Belg; 2004 Aug; 104(4):371-2. PubMed ID: 15469144 [No Abstract] [Full Text] [Related]
15. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain. James JS AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151 [TBL] [Abstract][Full Text] [Related]
16. Novartis agrees to pay $390m in US kickback case. McCarthy M BMJ; 2015 Oct; 351():h5784. PubMed ID: 26511869 [No Abstract] [Full Text] [Related]
17. Record settlement. PharMerica resolves kickback allegations. Taylor M Mod Healthc; 2005 Apr; 35(14):16. PubMed ID: 15825953 [No Abstract] [Full Text] [Related]
18. Changing the marketing message. Navarro RP Med Interface; 1995 Jun; 8(6):83-5. PubMed ID: 10142946 [No Abstract] [Full Text] [Related]
19. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors. Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098 [No Abstract] [Full Text] [Related]
20. US judge fines Johnson & Johnson $1.1bn for misleading marketing of risperidone. Tanne JH BMJ; 2012 Apr; 344():e2772. PubMed ID: 22508952 [No Abstract] [Full Text] [Related] [Next] [New Search]